Texas A&M Football
Sponsored by

Alabama and The Advantage Center

3,183 Views | 5 Replies | Last: 1 yr ago by NowhereMan
Only Fans Director
How long do you want to ignore this user?
Pretty smart idea to help athletes negotiate NIL opportunities. I imagine other schools will follow.

"As part of a new 15-year agreement with Alabama that it announced Tuesday, Learfield, in conjunction with the university, is creating a dedicated hub for name, image and likeness (NIL) called The Advantage Center, an epicenter for Crimson Tide athletes' NIL endeavors that the company believes is a first nationally."

https://www.si.com/college/2023/01/24/alabama-partners-new-nil-deal-sports-marketing-learfield




Dr. Horrible
How long do you want to ignore this user?
You know we've had a hub like that for well over a year…
Only Fans Director
How long do you want to ignore this user?
Dr. Horrible said:

You know we've had a hub like that for well over a year…
Is it partnered with a sports marketing giant like Bama?
Decay
How long do you want to ignore this user?
AG
Nattie said:

Dr. Horrible said:

You know we've had a hub like that for well over a year…
Is it partnered with a sports marketing giant like Bama?


Probably?
DustysLineup
How long do you want to ignore this user?
AG
Nattie said:

Dr. Horrible said:

You know we've had a hub like that for well over a year…
Is it partnered with a sports marketing giant like Bama?

You mean Learfield? Or Bama?

Obviously we are not on Bama's level, but Leafield has been involved in our radio broadcasting for years, and I have no idea what else now.
NowhereMan
How long do you want to ignore this user?
Oh boy a radio station deal learfield dominate AM radio.
The collectives are winning because no serious advertiser would pay a player the money they ate getting. NIL is a sham to legalize what got SMU the death penalty. Learfield is not a big deal.
Refresh
Page 1 of 1
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.